Morteza Hashemzadeh-Chaleshtori

Morteza Hashemzadeh-Chaleshtori

Auto-generated profile, based on publicly available information

Morteza Hashemzadeh-Chaleshtori

Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2017 in Antioxidants
Verified
Journal Article
Open access
PDF file
FAFereshteh Ahmadinejad
Fereshteh Ahmadinejad
SMSimon Moller
Simon Moller
MHMorteza Hashemzadeh-Chaleshtori
Morteza Hashemzadeh-Chaleshtori
GBGholamreza Bidkhori
Gholamreza Bidkhori
MJMohammad-Saeid Jami
Mohammad-Saeid Jami
Accumulating evidence shows that oxidative stress is involved in a wide variety of human diseases: rheumatoid arthritis, Alzheimer’s disease, Parkinson’s disease, cancers, etc. Here, we discuss the significance of oxidative conditions in different disease, with the focus on neurodegenerative disease including Parkinson’s disease, which is mainly caused by oxidative stress. Reactive oxygen and nitrogen species (ROS and RNS, respectively), collectively known as RONS, are produced by cellular enzymes such as myeloperoxidase, NADPH-oxidase (nicotinamide adenine dinucleotide phosphate-oxidase) and nitric oxide synthase (NOS). Natural antioxidant systems are categorized into enzymatic and non-enzymatic antioxidant groups. The former includes a number of enzymes such as catalase and glutathione peroxidase, while the latter contains a number of antioxidants acquired from dietary sources including vitamin C, carotenoids, flavonoids and polyphenols. There are also scavengers used for therapeutic purposes, such as 3,4-dihydroxyphenylalanine (L-DOPA) used routinely in the treatment of Parkinson’s disease (not as a free radical scavenger), and 3-methyl-1-phenyl-2-pyrazolin-5-one (Edaravone) that acts as a free radical detoxifier frequently used in acute ischemic stroke. The cell surviving properties of L-DOPA and Edaravone against oxidative stress conditions rely on the alteration of a number of stress proteins such as Annexin A1, Peroxiredoxin-6 and PARK7/DJ-1 (Parkinson disease protein 7, also known as Protein deglycase DJ-1). Although they share the targets in reversing the cytotoxic effects of H2O2, they seem to have distinct mechanism of function. Exposure to L-DOPA may result in hypoxia condition and further induction of ORP150 (150-kDa oxygen-regulated protein) with its concomitant cytoprotective effects but Edaravone seems to protect cells via direct induction of Peroxiredoxin-2 and inhibition of apoptosis.

1 October 2012 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
ISIsabelle Schrauwen
Isabelle Schrauwen
SHSarah Helfmann
Sarah Helfmann
AIAkira Inagaki
Akira Inagaki
FPFriederike Predoehl
Friederike Predoehl
MTMohammad Amin Tabatabaiefar
Mohammad Amin Tabatabaiefar
GCGuy Van Camp
Guy Van Camp

3 February 2015 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
ZHZohreh Hojati
Zohreh Hojati
RMRazieh Molaie
Razieh Molaie
AGAbolfazl Gholipour
Abolfazl Gholipour
BZBehnam Zamanzad
Behnam Zamanzad
MHMorteza Hashemzadeh
Morteza Hashemzadeh
Background: Urinary tract infections (UTIs) are one of main health problems caused by many microorganisms, including uropathogenic Escherichia coli (UPEC). UPEC strains are the most frequent pathogens responsible for 85% and 50% of community and hospital acquired UTIs, respectively. UPEC strains have special virulence factors, including type 1 fimbriae, which can result in worsening of UTIs. Objectives: This study was performed to detect type 1 fimbriae (the FimH gene) among UPEC strains by molecular method. Materials and Methods: A total of 140 isolated E. coli strains from patients with UTI were identified using biochemical tests and then evaluated for the FimH gene by polymerase chain reaction (PCR) analysis. Results: The UPEC isolates were identified using biochemical tests and were screened by PCR. The fimH gene was amplified using specific primers and showed a band about 164 bp. The FimH gene was found in 130 isolates (92.8%) of the UPEC strains. Of 130 isolates positive for the FimH gene, 62 (47.7%) and 68 (52.3%) belonged to hospitalized patients and outpatients, respectively. Conclusions: The results of this study indicated that more than 90% of E. coli isolates harbored the FimH gene. The high binding ability of FimH could result in the increased pathogenicity of E. coli; thus, FimH could be used as a possible diagnostic marker and/or vaccine candidate. Keywords: Urinary Tract Infections; Uropathogenic Escherichia Coli; FimH


1 February 2014 in Microbial Pathogenesis
Verified
Journal Article
Closed access
GRGhorbanali Rahimian
Ghorbanali Rahimian
MSMohammad Hosein Sanei
Mohammad Hosein Sanei
HSHedayatollah Shirzad
Hedayatollah Shirzad
FAFatemeh Azadegan-Dehkordi
Fatemeh Azadegan-Dehkordi
ATAfshin Taghikhani
Afshin Taghikhani
NBNader Bagheri
Nader Bagheri

1 January 2015 in Advanced Biomedical Research
Verified
Journal Article
Open access
MHMorteza Hashemzadeh-Chaleshtori
Morteza Hashemzadeh-Chaleshtori
HJHamideh Jafari-Ghahfarokhi
Hamideh Jafari-Ghahfarokhi
MMMaryam Moradi-Chaleshtori
Maryam Moradi-Chaleshtori
Thomas LiehrThomas Liehr
Thomas Liehr
HTHossein Teimori
Hossein Teimori
PGPayam Ghasemi-Dehkordi
Payam Ghasemi-Dehkordi
A small supernumerary marker chromosome (sSMC) is a structurally abnormal chromosome. It is an additional chromosome smaller than one chromosome most often lacking a distinct banding pattern and is rarely identifiable by conventional banding cytogenetic analysis. The origin and composition of an sSMC is recognizable by molecular cytogenetic analysis. These sSMCs are seen in different shapes, including the ring, centric minute, and inverted duplication shapes. The effects of sSMCs on the phenotype depend on factors such as size, genetic content, and the level of the mosaicism. The presence of an sSMC causes partial tris- or tetrasomy, and 70% of the sSMC carriers are clinically normal, while 30% are abnormal in some way. In 70% of the cases the sSMC is de novo, in 20% it is inherited from the mother, and in 10% it is inherited from the father. An sSMC can be causative for specific syndromes such as Emanuel, Pallister-Killian, or cat eye syndromes. There may be more specific sSMC-related syndromes, which may be identified by further investigation. These 10 syndromes can be useful for genetic counseling after further study.